Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/169101
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis |
Autor: | Ramos, Teresa L.; Sánchez-Abarca, Luis Ignacio; Rosón, Beatriz CSIC; Redondo, Alba; Rico, Ana; Preciado, Silvia; Ortega, Rebeca CSIC; Rodríguez, Concepción; Muntión, Sandra; Hernández-Hernández, Ángel CSIC ORCID; De Las Rivas, Javier CSIC ORCID CVN ; González, Marcos CSIC ORCID ; González-Porras, José R.; Cañizo, María Consuelo del; Sánchez-Guijo, Fermín M. CSIC ORCID | Fecha de publicación: | 2017 | Editor: | Public Library of Science | Citación: | PLoS ONE 12(8): e0182470 (2017) | Resumen: | There is evidence of continuous bidirectional cross-talk between malignant cells and bone marrow-derived mesenchymal stromal cells (BM-MSC), which favors the emergence and progression of myeloproliferative neoplastic (MPN) diseases. In the current work we have compared the function and gene expression profile of BM-MSC from healthy donors (HD-MSC) and patients with MPN (JAK2V617F), showing no differences in the morphology, proliferation and differentiation capacity between both groups. However, BM-MSC from MPN expressed higher mean fluorescence intensity (MIF) of CD73, CD44 and CD90, whereas CD105 was lower when compared to controls. Gene expression profile of BM-MSC showed a total of 169 genes that were differentially expressed in BM-MSC from MPN patients compared to HD-MSC. In addition, we studied the ability of BM-MSC to support the growth and survival of hematopoietic stem/progenitor cells (HSPC), showing a significant increase in the number of CFU-GM colonies when MPN-HSPC were co-cultured with MPN-MSC. Furthermore, MPN-MSC showed alteration in the expression of genes associated to the maintenance of hematopoiesis, with an overexpression of SPP1 and NF-kB, and a downregulation of ANGPT1 and THPO. Our results suggest that BM-MSC from JAK2 patients differ from their normal counterparts and favor the maintenance of malignant clonal hematopoietic cells. | Versión del editor: | https://doi.org/10.1371/journal.pone.0182470 | URI: | http://hdl.handle.net/10261/169101 | DOI: | 10.1371/journal.pone.0182470 | Identificadores: | doi: 10.1371/journal.pone.0182470 e-issn: 1932-6203 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
mesenhema.pdf | 9,19 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
11
checked on 06-abr-2024
SCOPUSTM
Citations
15
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
16
checked on 28-feb-2024
Page view(s)
301
checked on 20-abr-2024
Download(s)
227
checked on 20-abr-2024